Big Pharma Watch: Manufacturers Thumb Nose at Drug Price Crisis
Jul 12, 2019
Drug Makers Continue Price-Gouging Patients as Americans Demand Accountability… Read More
© 2024 CSRXP- All Rights Reserved
Updates
Second Opinion: Correcting Big Pharma’s Claims On The Rebate Rule
Jul 12, 2019
America’s seniors and taxpayers received a huge win today when the… Read More
CSRxP Applauds Administration for Withdrawal of Controversial Rebate Rule
Jul 11, 2019
Decision to Sideline Misguided Proposal a Huge Win for America’s Seniors… Read More
CSRxP: STRONGER Patents Act Could Further Enable Big Pharma’s Patent Abuse
Jul 10, 2019
Proposed Bill Would Undermine Fair and Efficient Review Process Washington,… Read More
In Case You Missed It: Congress must capitalize on momentum to hold Big Pharma accountable
Jul 9, 2019
Lauren Aronson The Hill July 9, 2019 The American people are demanding that… Read More
CSRxP: Judiciary Committee Cracks Down on Big Pharma’s Anti-Competitive Tactics
Jun 27, 2019
Senators Advance Three Measures to Help Lower Drug Prices as Momentum to Hold… Read More
CSRxP Applauds Senate HELP Committee For Advancing Bipartisan Measures to Hold Big Pharma Accountable and Lower Drug Prices
Jun 26, 2019
Advancement of CREATES and FAIR Drug Pricing Acts Marks Step Toward Boosting… Read More
Two Birds of a Feather: AbbVie to Acquire Fellow Price-Gouger Allergan In Multi-Billion Dollar Deal
Jun 26, 2019
This week, Big Pharma giant AbbVie announced plans to acquire drug maker… Read More
CSRxP Applauds HELP Committee for Taking Up Bipartisan CREATES Act
Jun 25, 2019
Encourages Senate Panel to Further Strengthen Drug Price Package with REMEDY… Read More
CSRxP: Study Demonstrates Big Pharma Must Be Held Accountable in Part D Reform
Jun 25, 2019
Report Finds Significant Catastrophic Liability for Drug Makers Benefits… Read More
THEY SAID IT! Senators on Aging Panel Pledge Bipartisan Action To Lower Drug Prices & Hold Big Pharma Accountable
Jun 20, 2019
Washington, D.C. – The U.S. Senate Special Committee on Aging held its third… Read More
CSRxP: Congress Must Amend USMCA to Protect American Patients
Jun 18, 2019
Current Trade Agreement Could Hamper Generic and Biosimilar Competition… Read More